Patented Medicine Prices Review Board's Jurisdiction Limited to Factory-Gate Prices of Patented Medicines - Tanya Weston

more+
less-

The Federal Court released a decision that impacts the authority of the Patented Medicine Prices Review Board (the “Board”) in respect of a patentee’s reporting requirements.[1] More particularly, the Federal Court has held that the Board does not have the authority to look beyond the factory gate price of a patentee’s product when assessing whether a patentee’s product is excessively priced.

LOADING PDF: If there are any problems, click here to download the file.


DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© MBM Intellectual Property Law LLP | Attorney Advertising

Written by:

more+
less-

MBM Intellectual Property Law LLP on:

JD Supra Readers' Choice 2016 Awards
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
×
Loading...
×
×